
    
      The Main objective of this study is to evaluate the faisibility of chemotherapy with
      Paraplatin in combination with Taxol in patients of 70 years or older with epithelial ovary
      cancer F.I.G.O. stages III and IV and to determine principal predictive factors of this
      feasibility.
    
  